V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007803 | 250005422 | 1.72 | 0 | Palliative (P) | 2013-04-18 | 2013-04-18 | Trial Unspecified | N | N | 250033031 | CYTARABINE |
| 250007804 | 250005423 | 1.55 | 75.8 | Disease modification (D) | 2016-07-03 | 2016-07-03 | DOXORUBICIN | 2 | N | 250033037 | VINORELBINE |
| 250007805 | 250005423 | 0 | 89 | Palliative (P) | 2015-07-30 | 2015-07-30 | EV + LOMUSTINE | N | N | 250033037 | TRIAL |
| 250007806 | 250005423 | 1.8 | 71.3 | Palliative (P) | 2015-01-14 | 2015-01-20 | GEMCARBO | N | N | 250033037 | CISPLATIN + PACLITAXEL |
| 250007807 | 250005424 | null | 52.5 | Disease modification (D) | 2015-09-02 | 2015-09-03 | Fluorouracil + Folinic + RT Bossett | null | null | 250033044 | RUXOLITINIB |
| 250007808 | 250005425 | 0 | 0 | Palliative (P) | 2013-12-31 | 2014-03-21 | GEMCARBO | N | N | 250033051 | TRIAL |
| 250007809 | 250005426 | 0 | 47.3 | Adjuvant (A) | 2016-02-04 | 2016-02-04 | MESO-02 TRIAL | N | N | 250033054 | TRIAL |
| 250007810 | 250005426 | 1.9 | 100 | Disease modification (D) | null | 2014-06-22 | Pemetrexed | N | N | 250033054 | IPM |
| 250007811 | 250005427 | 1.8 | 70.5 | Disease modification (D) | 2015-12-04 | 2015-12-06 | CHOP R | 02 | N | 250033056 | CYTARABINE |
| 250007812 | 250005427 | 1.53 | 54.4 | Disease modification (D) | 2013-08-12 | 2014-11-05 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250033056 | TRIAL |
| 250007813 | 250005428 | null | 87.5 | Disease modification (D) | 2016-05-08 | 2016-05-08 | Trial Unspecified | 02 | N | 250033059 | IPM |
| 250007814 | 250005429 | null | 71.5 | Curative (C) | null | 2014-08-02 | Trial Unspecified | null | N | 250033063 | CHOP R |
| 250007815 | 250005430 | 1.7 | 0 | Disease modification (D) | 2014-04-14 | 2014-04-14 | Trial Unspecified | 2 | N | 250033066 | RUXOLITINIB |
| 250007816 | 250005431 | 1.58 | 77.5 | Palliative (P) | 2016-11-03 | 2016-11-03 | Capecitabine + Oxaliplatin 21day | N | N | 250033067 | RUXOLITINIB |
| 250007817 | 250005432 | null | 73 | Disease modification (D) | 2015-01-30 | 2015-01-30 | CISPLATIN + GEMCITABINE | N | N | 250033069 | PEMETREXED |
| 250007818 | 250005433 | 1.56 | 79.8 | Adjuvant (A) | null | 2018-06-20 | CARBOPLATIN + ETOPOSIDE | N | N | 250033070 | CARBOPLATIN + PACLITAXEL |
| 250007819 | 250005433 | 1.63 | 0 | Curative (C) | 2018-06-23 | 2018-07-02 | IPM | N | N | 250033070 | AZACITIDINE |
| 250007820 | 250005434 | null | 0 | Disease modification (D) | 2017-02-04 | 2017-02-04 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 250033073 | FLAG + IDARUBICIN |
| 250007821 | 250005435 | 1.55 | 83.6 | Disease modification (D) | 2015-09-26 | 2015-09-26 | Pemetrexed | 02 | N | 250033075 | CISPLATIN + GEMCITABINE |
| 250007822 | 250005435 | 1.5 | null | Disease modification (D) | 2014-02-24 | 2014-02-27 | Trial Unspecified | 2 | N | 250033075 | EC |
| 250007823 | 250005436 | 0 | 85.4 | Palliative (P) | 2015-10-26 | 2015-10-26 | Vinorelbine (oral) | 01 | N | 250033078 | CARBOPLATIN |
| 250007824 | 250009842 | 1.7 | 86.8 | Curative (C) | 2014-10-16 | 2014-10-16 | CAPECITABINE + OXALIPLATIN | 1 | N | 250033084 | CARBOPLATIN + PACLITAXEL |
| 250007825 | 250009842 | 1.65 | null | Curative (C) | 2017-04-30 | 2017-05-04 | IPM | 02 | N | 250033084 | TRIAL |
| 250007826 | 250005437 | null | 90 | Palliative (P) | 2014-01-22 | 2014-01-22 | CARBOPLATIN + VINORELBINE | N | N | 250033098 | TRIAL |
| 250007827 | 250005437 | 1.58 | 88 | Disease modification (D) | 2015-12-05 | 2015-12-05 | FLAG | 2 | N | 250033098 | ATG + BUSULFAN + FLUDARABINE |
| 250007828 | 250005437 | 0 | 69 | Disease modification (D) | 2013-09-15 | 2013-09-15 | PEG INTERFERON | 02 | N | 250033098 | DA |
| 250007829 | 250005438 | 1.74 | 97.7 | Palliative (P) | 2016-03-30 | 2016-03-30 | MESO-02 TRIAL | 02 | N | 250033110 | TRIAL |
| 250007830 | 250005439 | 1.63 | null | Adjuvant (A) | 2017-08-21 | 2017-08-21 | CARBOPLATIN + ETOPOSIDE | 01 | N | 250033112 | GEMCARBO |
| 250007831 | 250009844 | 1.63 | 74.2 | Palliative (P) | 2014-07-04 | 2014-07-08 | VINORELBINE | 02 | N | 250033113 | IPM |
| 250007832 | 250005440 | 1.75 | 61.2 | Disease modification (D) | 2015-06-18 | 2015-06-18 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | N | N | 250033115 | AZACITIDINE |
| 250007833 | 250009845 | 1.67 | 60 | Palliative (P) | 2014-03-02 | 2014-03-02 | Temozolomide 150mg/m2 | N | Y | 250033117 | VINORELBINE |
| 250007834 | 250005441 | 0 | 0 | Unknown (U) | 2013-08-24 | 2013-09-27 | RUXOLITINIB | N | N | 250033119 | PEMETREXED |
| 250007835 | 250005442 | 1.76 | 50.6 | Disease modification (D) | 2017-02-28 | 2017-02-28 | Trial Unspecified | 1 | N | 250033123 | CISPLATIN + GEMCITABINE |
| 250007836 | 250005442 | null | 125 | Palliative (P) | 2018-07-27 | 2018-07-27 | Trial Unspecified | 02 | N | 250033123 | CAPECITABINE |
| 250007837 | 250005442 | 1.58 | null | Palliative (P) | 2015-07-12 | 2015-07-12 | IPM | 2 | N | 250033123 | CISPLATIN + PACLITAXEL |
| 250007838 | 250005443 | null | null | Palliative (P) | 2016-12-19 | 2017-01-06 | Pemetrexed | N | N | 250000264 | ECX |
| 250007839 | 250005444 | 1.67 | 75 | null | 2017-05-10 | 2017-05-10 | VEPEMB | N | N | 250000299 | CARBOPLATIN + PACLITAXEL |
| 250007840 | 250005444 | null | null | Curative (C) | 2017-12-20 | 2017-12-24 | Vinorelbine (oral) | 1 | N | 250000299 | NOT MATCHED |
| 250007841 | 250005444 | null | null | Palliative (P) | 2018-05-26 | 2018-05-26 | Doxorubicin + Olaratumab | 02 | N | 250000299 | IPM |
| 250007842 | 250005445 | null | null | Curative (C) | 2019-03-07 | 2019-03-07 | Pemetrexed | 02 | N | 250000381 | PEMETREXED |
| 250007843 | 250005445 | 1.69 | 84.8 | Adjuvant (A) | 2017-08-19 | 2017-08-20 | IPM | N | null | 250000381 | VINORELBINE |
| 250007844 | 250005445 | null | null | Palliative (P) | 2016-10-25 | 2016-10-25 | Trial Unspecified | Y | N | 250000381 | CARBOPLATIN |
| 250007845 | 250005446 | 1.61 | 67.2 | Disease modification (D) | 2015-08-14 | 2015-08-14 | Cisplatin | N | N | 250000611 | TRIAL |
| 250007846 | 250005447 | 1.78 | 83.55 | Neo-adjuvant (N) | 2016-10-09 | 2016-10-12 | VINORELBINE | null | null | 250000664 | VINORELBINE |
| 250007847 | 250005448 | null | null | null | 2014-05-16 | 2014-05-16 | Trial Unspecified | 2 | N | 250000724 | CAPECITABINE + CISPLATIN |
| 250007848 | 250009849 | 1.75 | 75.6 | Palliative (P) | 2013-11-09 | 2013-12-16 | Trial Unspecified | 02 | Y | 250000755 | CHOP R |
| 250007849 | 250005449 | 1.65 | 41.2 | Disease modification (D) | 2017-03-22 | 2017-04-16 | GEMCITABINE | N | N | 250000923 | VINORELBINE |
| 250007850 | 250005449 | 1.78 | 73.6 | Adjuvant (A) | 2018-07-07 | 2018-07-11 | Pemetrexed | Y | N | 250000923 | TRIAL |
| 250007851 | 250005449 | 1.82 | 80.4 | Palliative (P) | 2013-08-09 | 2013-08-09 | Trial Unspecified | N | N | 250000923 | CYTARABINE |
| 250007852 | 250005450 | 1.74 | null | Curative (C) | 2018-11-21 | 2018-11-21 | Vinorelbine IV | 99 | null | 250001102 | DOCETAXEL |